(Q40351752)

19 September 2017

title

Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). (English)

1 reference

19 September 2017

1 reference

2

Harvey F Lodish

1 reference

19 September 2017

Alec W Gross

1

1 reference

19 September 2017

language of work or name

English

0 references

publication date

11 November 2005

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

4

1 reference

19 September 2017

page(s)

2024-2032

1 reference

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Role of glycosylation on the secretion and biological activity of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Pathophysiology of cardiovascular damage in the early renal population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Enhancement of therapeutic protein in vivo activities through glycoengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Control of rHuEPO biological activity: the role of carbohydrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Erythropoietin receptor mRNA expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Emerging biological roles for erythropoietin in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching".

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510493200

21 January 2018

Identifiers

DOI

10.1074/JBC.M510493200

1 reference

19 September 2017

1 reference